/stocks — the workspaceLOADING
Medpace Holdings, Inc. (MEDP) is a services-commercial physical & biological research company. Piotroski F-Score 6/7. 14 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-07-20 from MEDP's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on MEDP plus an auto-SWOT — built from MEDP's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate MEDP using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| David J. TaylorU.S. Representative · OH-02 | BUY | $1,001 - $15,000 | filed 2026-05-28 |
Projected from MEDP's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment MEDP files its announcement.
MEDP has sold off after 6 of its last 8 earnings reports.
Large earnings reactions have been common.
MEDP has traded lower after most recent earnings releases.
The average is inflated by its most volatile prints (+53.2% and -23.6%).
A more typical earnings reaction has been approximately ±12.3%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-04-22 | -23.6% |
| 2026-02-09 | -17.7% |
| 2025-10-22 | +9.3% |
| 2025-07-21 | +53.2% |
| 2025-04-21 | -4.7% |
| 2025-02-10 | -7.4% |
| 2024-10-21 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| -8.4% |
| 2024-07-22 | -15.2% |
| EWALD STEPHEN PGeneral Counsel & Corp. Secy. | SELL | $7.4M | view → |
| GEIGER JESSE JPresident | SELL | $14.4M | view → |